According to a recent LinkedIn post from Artera, the company’s AI-based patient outreach technology is being used in a partnership with Atlantic Health to support colorectal cancer screening workflows. The post frames colonoscopy preparation and patient follow‑through as key execution gaps, despite high survival rates associated with early cancer detection.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
As described in the post, Artera’s AI agents contact patients one week before scheduled colonoscopies to confirm appointments, review preparation materials, and address questions. Reported 30‑day results include 43% of patients answering and confirming their identities, 39% explicitly confirming appointments, and a 38% reduction in manual call time for staff.
From an investor perspective, the partnership suggests growing demand for AI‑driven workflow automation in healthcare, particularly in high-value, procedure-based specialties. If such deployments scale across health systems, Artera could benefit from recurring software revenue, stronger integration into clinical operations, and enhanced data assets that may reinforce its competitive position.
The reported reduction in staff call time may resonate with hospital and health system customers facing labor constraints and cost pressures. Successful case studies like the one referenced, including coverage in outlets such as Becker’s Healthcare, could support Artera’s go‑to‑market efforts and strengthen its standing among digital health and AI vendors focused on closing care gaps.